development of immunotherapy against cancer. Mucin‐type glycopeptides have been successfully investigated as molecularly defined vaccine prototypes for triggering humoral immunity but are susceptible to rapid in vivo degradation. As a potential means to enhance the bioavailabilities of the antigenic structures, hydrolysis‐resistant carbohydrate analogues with fluorine substituents at positions C6, C2′ and
粘
蛋白糖蛋白在上皮肿瘤细胞上的异常糖基化概况代表了针对癌症的免疫疗法发展的有吸引力的靶结构。粘蛋白型糖肽已作为分子定义的疫苗原型成功进行了研究,可触发体液免疫,但易于在体内迅速降解。作为增强抗原结构
生物利用度的潜在手段,合成了在位置C6,C2'和C6'具有
氟取代基的耐
水解
碳水化合物类似物,并将其掺入粘蛋白MUC1的串联重复序列中。由此产生的伪糖肽可用于阐明
化学修饰的
抗体决定簇对代谢和免疫学特性的影响。